Dermata Therapeutics, Inc.

DRMA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2-$2-$2-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$1$0$0
Other Non-Cash$0$0$0$0
Operating Cash Flow-$2-$3-$2-$3
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$0-$1$8-$0
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$0-$1$8-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$3$7-$3
Supplemental Information
Beg. Cash$6$10$3$6
End Cash$5$6$10$3
Free Cash Flow-$2-$3-$2-$3
Dermata Therapeutics, Inc. (DRMA) Financial Statements & Key Stats | AlphaPilot